尹

尹丰 (Feng Yin)

Shenzhen Bay Laboratory

H指数:35

被引数:4,396

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Categorizing missed nursing care to effectively investigate its influencing factors among pediatric nurses: a regional cross-sectional survey

对儿科护士遗漏护理进行分类，以有效调查其影响因素：一项区域性横断面调查

BMC Nursing

IF3.9

2025-12-160

OAAI

Targeted RNA Degradation via LipoSM-RiboTAC Nanoparticles: A Versatile Platform for Cancer Therapy

靶向RNA降解通过LipoSM-RiboTAC纳米颗粒：一种用于癌症治疗的通用平台

Journal of the American Chemical Society

IF15.6

2025-10-180

PRE

Association of ficolin single nucleotide polymorphism with systemic lupus erythematosus in the Chinese Han Population

中国汉族人群纤维胶凝蛋白单核苷酸多态性与系统性红斑狼疮的关联

RHEUMATOLOGY AND IMMUNOLOGY RESEARCH

IF2.5

2025-10-040

PRE

Silencing Myostatin Using In Vivo Self-Assembled siRNA Protects Against Cancer- and Dexamethasone-Induced Muscle Atrophy

使用体内自组装siRNA沉默肌生成抑制素可对抗癌症及地塞米松诱导的肌肉萎缩

Advanced Healthcare Materials

IF9.6

2025-10-030

OAAI

EGFR Targeted Liposomal PROTAC Assisted With Epigenetic Regulation as an Efficient Strategy for Osimertinib-Resistant Lung Cancer Therapy

EGFR靶向脂质体PROTAC联合表观遗传调控作为奥希替尼耐药肺癌治疗的高效策略

Advanced Science

IF14.1

2025-08-210

OAAI

A Unified Peptide Generative Framework via a Weakly Order-Dependent Autoregressive Language Model and Lifelong Learning

基于弱序依赖自回归语言模型和终身学习的一体化多肽生成框架

Journal of Chemical Information and Modeling

IF5.3

2025-08-010

PRE

Predicting protein stability changes upon mutations with dual-view ensemble learning from single sequence

基于单序列的双视角集成学习方法预测突变引起的蛋白质稳定性变化

BRIEFINGS IN BIOINFORMATICS

IF7.7

2025-07-010

OAAI

Current progress and remaining challenges of peptide-drug conjugates (PDCs): next generation of antibody-drug conjugates (ADCs)?

肽偶联药物（PDCs）的当前进展与待解决问题：下一代抗体偶联药物（ADCs）？

JOURNAL OF NANOBIOTECHNOLOGY

IF12.6

2025-04-220

Emerging zoonotic potential of H4N1 avian influenza virus: enhanced human receptor binding and replication via novel mutations

H4N1禽流感病毒的潜在新兴人畜共患特性：通过新型突变增强与人受体结合及复制能力

VIROLOGY JOURNAL

IF3.8

2025-04-180

Programmable Stapling Peptide Based on Sulfonium as Universal Vaccine Adjuvants for Multiple Types of Vaccines

基于硫鎓的编程式订书钉肽作为多种类型疫苗的通用疫苗佐剂

ADVANCED SCIENCE

IF14.1

2025-01-291

OAAI

Self-assembly of a cyclo-pentapeptide with a novel frame structure

具有新颖骨架结构的环五肽的自组装

Chinese Chemical Letters

IF8.9

2024-12-240

PRE

Peptide Nanocarriers for Targeted Delivery of Nucleic Acids for Cancer Therapy

BIOCONJUGATE CHEMISTRY

IF3.9

2024-12-230

PRE

In-Depth Structural Analysis of a Stapled Pentapeptide and Its Assembly Into Straight α-Helices

SMALL

IF12.1

2024-12-040

PRE

Versatile Split-and-Mix Liposome PROTAC Platform for Efficient Degradation of Target Protein In Vivo

通用的拆分混合脂质体PROTAC平台可在体内有效降解目标蛋白

JACS AU

IF8.7

2024-07-110

OAAI

A Novel Lysosome Targeting Chimera for Targeted Protein Degradation via Split-and-Mix Strategy

ACS CHEMICAL BIOLOGY

IF3.8

2024-04-254

PRE

Sulfonium-Stapled Peptides-Based Neoantigen Delivery System for Personalized Tumor Immunotherapy and Prevention

ADVANCED SCIENCE

IF14.1

2024-04-112

Integrative Analysis of Multi-Omic Data for the Characteristics of Endometrial Cancer

ACS OMEGA

IF4.3

2024-03-130

OAAI

Single-domain antibodies against SARS-CoV-2 RBD from a two-stage phage screening of universal and focused synthetic libraries

从通用和聚焦合成文库的两阶段噬菌体筛选中获得针对SARS-CoV-2 RBD的单域抗体

BMC INFECTIOUS DISEASES

IF3

2024-02-132

OAAI

Traceless Peptide and Protein Modification via Rational Tuning of Pyridiniums

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

IF15.6

2024-01-197

PRE

Covalent PROTAC design method based on a sulfonyl pyridone probe

CHEMICAL COMMUNICATIONS

IF4.2

2024-01-0110

PRE

研究方向

多肽方法学开发生物医学应用蛋白-蛋白相互作用多肽工程战略蛋白修饰ADC/PDC/ODC药物构建活细胞标记ABPP位点归类新颖的可控稳定多肽自组装核酸药物运载体的开发肿瘤siRNA运载体核酸运载体多肽运载体肿瘤免疫治疗简单易制备混合即用且可包含多条肿瘤新抗原肽的共递送纳米平台

Zigang Li

H 指数:28论文数:131被引数:3,275

Zigang Li

H 指数:31论文数:146被引数:3,296

Rui Wang

H 指数:37论文数:254被引数:5,611

万川

H 指数:30论文数:108被引数:2,575

侯

侯占峰

H 指数:18论文数:147被引数:1,232

Dongyuan Wang

H 指数:24论文数:103被引数:2,128

Chenshan Lian

H 指数:12论文数:41被引数:406

Ken‐Tye Yong

H 指数:79论文数:399被引数:2.3万

H 指数:34论文数:197被引数:4,377